_super-strong-magnet-literally-blew-the-doors-off-a-tokyo-laboratory.jpg "Super-Strong Magnet Literally Blew the Doors Off a Tokyo Laboratory from rmr laboratories Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 0:47
👁 View: 1M times
✓ Published: 12-May-2024
👁 View: 1M times
✓ Published: 12-May-2024
Description:
There's a magnet in a secure room in central Tokyo. It's an electromagnet, the kind that generates a magnetic field when electrical current flows through it. The last time the scientists who operate it switched it on, it blew open the heavy doors designed to keep it contained. Already, it has created one of the most intense magnetic fields ever generated on Earth. And it keeps getting more powerful.
There's a magnet in a secure room in central Tokyo. It's an electromagnet, the kind that generates a magnetic field when electrical current flows through it. The last time the scientists who operate it switched it on, it blew open the heavy doors designed to keep it contained. Already, it has created one of the most intense magnetic fields ever generated on Earth. And it keeps getting more powerful.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_rmr-laboratories-live-panel-with-product-users-amp-ceo.webp "Leila Fenelon")
_introduction-to-rmr-lab.webp "Wayne State")
_cathie-wood39s-ark-invest39s-third-largest-holding-is-this-little-known-biotech-company-harnessing-ai-for-drug-treatment.webp "Cathie Wood's ARK Invest has been buying shares of Recursion Pharmaceuticals, a biotech company using AI to speed up drug discovery. It is now the third-largest holding in her ARK Genomic Revolution ETF. Recursion has developed an AI-powered operating system that conducts up to 2.2 million weekly experiments to test drug candidates in an automated laboratory, advancing only the most promising compounds to clinical trials. Using AI this way could allow Recursion to launch drugs faster than competitors and license its OS to other companies, building a network effect that improves its algorithm over time.")
_lab-3-rmr-part-1.webp "Mike Jett")
_rmr-laboratories-live-panel-with-product-users-amp-ceo.jpg)
_introduction-to-rmr-lab.jpg)
_cathie-wood39s-ark-invest39s-third-largest-holding-is-this-little-known-biotech-company-harnessing-ai-for-drug-treatment.jpg)
_lab-3-rmr-part-1.jpg)
![[+]](/images/menu.gif){kind=small}